Rebirth 1999: Opening the Age of Black Technology

v1 Chapter 607: If you want to get agency rights, you mu

Qu Ping quickly followed Chen Xiao's request and immediately announced the relevant announcements and requirements for the global bidding of Changtian Technology's joint colony therapy and joint energy colony therapy.

At this moment, companies such as Bristol-Myers Squibb, Johnson & Johnson, and Pfizer are still in Changzezhou and have not left.

The three companies did not expect Changtian Technology to play this trick.

However, this is an absolute benefit for the three companies.

Everyone knows that combined colony therapy and combined energy bacteria therapy are unique monopoly technologies in the world, one can complete the treatment of severe lung diseases, and the other can solve the problem of diabetes from the root.

If he could obtain the agency right, it would of course mean endless wealth in the future!

What is the best way to make money!

Of course, the monopoly business is the most profitable.

After seeing the announcement of Changtian Technology, companies such as Bristol-Myers Squibb and Pfizer immediately returned to the United States to prepare relevant materials.

In fact, all the conditions proposed by Changtian Technology are easy to meet, and the most difficult thing to meet is the medical admission qualification in the United States.

But when it comes to money, everything is possible.

Pfizer has it all figured out.

On the one hand, Pfizer will definitely try its best to persuade the relevant departments in the United States, hoping that the combined bacterial colony therapy can be certified by the US FDA as soon as possible.

However, according to the efficiency of the United States, even if there are congressmen or capital to put pressure on the relevant departments of the United States, the process will be very long.

So Pfizer is going to prepare with both hands. The second aspect is to go to the "colony" of the United States, Puerto Rico, or Mexico, the back garden, to promote the treatment plan first, so that the people of the United States can receive treatment.

Both Poland and Mexico are very close to the United States, and the laws here are not strict. It is best to do things like medical treatment.

The solution is to think about it. What Pfizer wants now is to obtain the agency rights of Changtian Technology.

Companies such as Johnson & Johnson and Best Myers Squibb also had this idea. They rushed home to report the relevant situation to the head office and prepared bidding materials.

Chen Xiao didn't expect that one of her own arrangements would cause the world's top ten pharmaceutical companies to lose their legs.

But the arrangement of Changtian Technology has made the relevant domestic departments nervous!

The relevant papers and clinical trial results of Changtian Technology's combined bacterial colony therapy and combined energy bacteria therapy have been repeatedly studied and discussed by relevant national departments, and finally hundreds of pages of research results have been obtained.

It is too wasteful to describe the research results of hundreds of pages. It can be summed up in two words—

Awesome!

After obtaining this result, the relevant departments immediately started the medical promotion process, including the two combined colony treatment plans of Changtian Technology in the general treatment plan, and applied to the superiors to include the corresponding treatment costs in the medical insurance.

However, the treatment cost of combined colony therapy is still relatively expensive, so it is not very realistic to be covered by medical insurance within a few years.

Even so, it is the best, if not the only, way to treat severe lung disease and diabetes.

Therefore, the relevant departments were very nervous when they learned that Changtian Technology was going to sell the treatment agency qualification. They were very worried that the relevant treatment technology would be mastered by the West again. The right to speak is lost in this way.

Yang Kai, the person in charge of medical and health care, felt that he couldn't speak clearly when he called Chen Xiao, so he quickly flew to Suzhou and Hangzhou with his team, and then called the special car of Suzhou and Hangzhou, and rushed to Changzhou on the same day. Zezhou and Chen Xiao met.

Yang Kai came to Changze Island in person, which made Chen Xiao a little flattered.

Chen Xiao immediately received Yang Kai and his party solemnly in the conference room, thinking that Yang Kai was coming to visit the life science and medical laboratory of Changtian Technology, and explore the therapeutic effect of combined exercise therapy.

Who knew that Yang Kai would never go to the laboratory or the treatment center at all, because through the papers published by Changtian Technology and the social reactions of patients who had already received treatment, Yang Kai knew that the treatment of Changtian Technology was absolutely true Effective.

Yang Kai waved his hand and said to Chen Xiao: "Mr. Chen, this time our team is not here to visit your laboratory, nor is it to question whether your therapy is compliant or effective."

"Since the state allows you to open a treatment center in Changzezhou, allowing you to treat patients on a large scale, it means that this treatment method is absolutely effective and is allowed by the state. We came this time because we heard that your company will I sold the treatment rights of joint exercise therapy and want to know about it.”

Yang Kai took a sip of tea and said: "We have passed all the certification procedures for combined colony therapy, and have planned to use this therapy as a standard treatment for severe lung diseases and diabetes. Hospitals and treatment centers will promote it, and we will ask for your cooperation from Changtian Technology at that time."

Chen Xiao probably knew the significance of this cooperation, which meant that the combined colony therapy of Changtian Technology would be promoted nationwide in an officially certified manner. It also means that the combination of this therapy can truly and thoroughly open up the domestic market.

In the future, Changtian Technology can dispatch medical personnel to each province to assist the hospitals in the subordinate cities of the province that are qualified to complete the combined bacterial colony therapy and complete relevant treatment activities.

Of course, Changtian Technology must make the biggest profit among them.

Yang Kai said anxiously: "We are very clear that combined bacterial colony therapy is a major breakthrough in the biomedical field. Combined bacterial colony therapy can completely treat severe lung diseases, and combined energy bacteria can completely treat diabetes. This treatment method is the first in the history of international medicine, and we Xia people can control the right to speak!"

Yang Kai has worked in the health system for many years, so he is very aware of the importance of this right to speak.

International biomedical technology is developed in a coordinated manner. It is not a country or a certain company that can rely on its own strength to master the most advanced biomedical technology in the world.

But if you don’t have a trump card in your hand, you are not qualified to negotiate with other countries. If you have some indispensable life-saving treatments or medicines, the other party can sell them to you at a high price regardless of your feelings, and you have no bargaining price. right.

But if you have one or two trump cards in your hand, you can negotiate with these Western countries and technology companies to form a win-win compromise for both parties.

In the past, Xia Guo's biomedical circle had very few trump cards, almost none. The so-called trump card was Xia Guo's large market.

Therefore, targeted anti-cancer drugs and high-end medical equipment from Western technology companies, especially pharmaceutical companies in the United States, will be sold in Xiaguo at ridiculously high prices, and Xiaguo has no choice but to accept them all.

Looking at the anxious Yang Kai and Chen Xiao, he smiled and said, "Only the agency right in the United States, not technology transfer!"

"And to tell you the truth, Changtian Technology has invested a lot of money in chip research and development, and also hopes to obtain cash flow at the fastest speed through technology transfer to support the company's development."

Gu Xiao

"We also hope that through this cooperation with American Pharmaceutical Company, we can gain more voice for the national biomedical industry."

"If the country is willing, this time our negotiation with a company in the United States can include a package of agreement conditions, including some necessary drugs and price reductions for medical devices, etc."

Hearing what Chen Xiao said, Yang Kai really breathed a sigh of relief.

Yang Kai thought about it, and felt that what Chen Xiao said was very reasonable.

Let Xiaguo's biomedical technology go out and let overseas patients feel that Xiaguo's medical technology is not inferior to theirs. Only in this way can we gradually accumulate the reputation of Xiaguo's medical industry overseas, and also make overseas critically ill patients unable to live without it. Kaixia's medical technology and related drugs.

The two sides need to have mutual needs to be able to further cooperate, and the relevant departments of the Xia Kingdom will have a higher say in negotiations with the American Pharmaceutical Company in the future.

Yang Kai said: "My side will immediately formulate a different package of negotiation conditions for these three pharmaceutical companies."

Yang Kai has worked in the medical sector for many years, and has dealt with companies such as Pfizer, Johnson & Johnson, and Bristol-Myers Squibb many times, so they are very familiar with the scarce resources in the hands of these pharmaceutical companies.

For example, certain high-end medical equipment, antiviral drugs, anticancer drugs, etc.

As long as Chen Xiao cooperates with any of these companies, Yang Kai will put forward different requirements for them, so as to satisfy Xia's medical market and save money for the country.

Chen Xiao and Yang Kai talked for a long time, and the two sides decided on the final plan.

When Yang Kai left, he was full of emotions, "If Xia Guo can have more technology companies like Changtian Technology, why worry about being unable to speak in the international medical industry."

Changtian Technology also made a supplementary agreement on the public bidding of overseas agency rights according to the results of discussions with relevant departments.

In addition to meeting the package negotiation conditions for Xiaguo's related pharmaceutical products and medical equipment, the lowest price for agency rights was also given.

No matter which company wins the bid, it must pay an agency fee of at least 3 billion dollars. After the agency right, the profit will be divided 50-50.

The starting price of 3 billion meters was given by Chen Xiao after weighing.

Because in 2006, the sales of several companies such as Pfizer have exceeded 10 billion meters, of which Pfizer has reached 30 billion meters. These companies also invest billions of dollars in research and development every year.

Therefore, it is difficult for these companies to charge an agency fee of 3 billion meters, which is acceptable or not.

If you don't accept it, then the huge profits in the future will fall into the hands of others, but if you accept it, it will be quite painful to take out the 3 billion meter knife.

After Changtian Technology announced a package of negotiation conditions, some of these pharmaceutical companies collapsed.

Cassian listened to the quarrel between the top management and shareholder representatives at the BEST-Myers Squibb high-level meeting. After some quarrels, they still chose to compromise and were ready to accept the conditions of Changtian Technology.

But whether to invest 3 billion meters or go up with 3 billion meters, everyone is a little hesitant.

Because if the price happens to be reported at 3 billion meters, if Pfizer and other companies offer a price of 3 billion meters or higher, then Bristol-Myers Squibb will definitely not be able to win the bid.

The time for the battle of wits and courage has begun.

Bristol-Myers Squibb, Pfizer, Johnson & Johnson and other companies compete and cooperate in the pharmaceutical industry, but they are generally cooperative.

Especially in the international market, with the support of the capital behind them, several pharmaceutical companies in the United States cooperated with each other to seize the market.

For example, Pfizer has developed a drug like Viagra to help men. This drug is very profitable, so companies such as Johnson & Johnson and Bristol-Myers Squibb will not develop similar drugs and give up the market to Pfizer.

And just as Bristol-Myers Squibb has developed anti-hepatitis drugs, Pfizer will be weaker in this regard and give up the market to Bristol-Myers Squibb.

Now Changtian Technology is asking these companies to compare prices with each other, which really makes the three companies very heartbroken.

In the end, Pfizer took the initiative and negotiated with Johnson & Johnson and Guibao respectively. In the end, the three parties decided to bid for Changtian Technology at a price of 3 billion meters. agency.

One company paid 1 billion meters, which also eased the economic pressure of the three pharmaceutical companies.

The plan jointly drafted by the three companies was submitted to Changtian Technology.

After seeing this plan, Chen Xiao smiled and said, "If they do this, I might as well not find an agent and continue to expand the combined bacterial colony therapy. In Xiaguo's treatment center, we welcome more American people to come. Xiaguo treatment, we can also build a treatment center in Mexico and other countries, so that it will be closer to the United States. UU Reading www.uukanshu.com”

That's what Chen Xiao said, but he knows that the actual operation is actually quite difficult, especially it is unrealistic to build the treatment center in Mexico. After all, Mexico is the back garden of the United States, and Changtian Technology has nothing to do with the United States. You will definitely be obstructed in every possible way, and you will not be able to do this kind of thing.

But businessmen, when negotiating, they must release all their words.

After learning of Changtian Technology's veto, the three parties immediately sent a delegation to negotiate with Changtian Technology.

Chen Xiao was also straightforward. Anyway, they built the hospital in the United States and put the treatment technology in the United States to make money.

There is no essential difference between one agent and three agents for Changtian Technology's profit, so Chen Xiao said: "Three agents are also fine, and the agency fee rises to 3.3 billion dollars. In addition, the other party must accept the package offered by Xia Guo. Negotiate a compromise!"

The package negotiation agreement proposed by the relevant departments of Xia State includes the price reduction of Pfizer's Lipitor, Norvasc, Celebrex, Viagra and other drugs, Bristol-Myers Squibb's Ixabepilone, Dasatinib and other drugs, as well as Johnson & Johnson's drugs and equipment.

The requirements of the relevant departments of Xia State are actually not high. It is not that the level of some drugs has been reduced so low, but that the price level of these drugs is comparable to that of the US or European markets.

After arduous negotiations, on the National Day in 2007.

Changtian Technology has reached a cooperation agreement with three pharmaceutical companies participating in the United States.

Three pharmaceutical companies in the United States spent a total of 3.3 billion dollars to obtain the agency rights of Changtian Technology's combined bacterial colony and combined energy bacteria therapy, and can carry out corresponding treatments in the United States and its territories.

After Yang Kai got the news in Yanjing, he who was over fifty years old raised his arms and shouted, and then shed tears of excitement.